Application of EGFP-CTA2-TAT fusion protein to preparation of fluorescent probe
An EGFP-CTA2-TAT and fusion protein technology, which is applied in the application field of EGFP-CTA2-TAT fusion protein in the preparation of fluorescent probes, and achieves the effects of improving sensitivity, no cytotoxicity, and good transmembrane activity.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0041] Embodiment 1 strain activation and glycerol tube preservation
[0042] (1) Plate preparation: LB solid medium ingredients, sterilized at 121°C for 30 minutes; light the alcohol lamp on the ultra-clean workbench with UV light on for 30 minutes in advance, and place the plate half-opened around the alcohol lamp; sterilized LB solid medium in the ultra-clean Cool the clean workbench to about 60°C, add ampicillin antibiotics (final concentration 50 μg / mL) and quickly pipette and shake well; finish pouring the plate before the medium solidifies, half-open the plate after pouring, open the workbench for ventilation, and cover it when the medium solidifies Wrap in plastic wrap for storage.
[0043] (2) Inoculation: a tube of 5mL LB liquid medium, first add 2.5μL ampicillin antibiotic stock solution (mother solution concentration 100mg / mL), then add 50μL E.coli BL21(DE3) containing recombinant plasmid pET22b-EGFP-CTA2-TAT Strain preservation solution; culture at 37°C, 200r / min...
Embodiment 2
[0047] The expansion culture of embodiment 2 target strains and the inducible expression of target protein
[0048] (1) The E.coli BL21 (DE3) monoclonal strain bacterial liquid containing the recombinant plasmid pET22b-EGFP-CTA2-TAT after the activation made in Example 1 is used in a volume ratio of 1:100 in a clean bench Inoculate into LB liquid medium containing ampicillin antibiotic (final concentration 50 μg / mL); then place at 37°C and culture overnight at 200 r / min on a shaker for 12 hours;
[0049] (2) On the ultra-clean workbench, transfer the bacterium liquid cultivated overnight in step (1) to the Erlenmeyer flask containing ampicillin antibiotic (final concentration 50 μg / mL) and LB liquid medium according to the volume ratio of 1:50; then Place on a 200r / min, 37°C shaker for 4 hours;
[0050] (3) Add IPTG with a final concentration of 1mmoL / L to the bacterial solution after the expanded culture in step (2); induce on a shaking table at 37°C and 200r / min for 5h;
...
Embodiment 3E
[0052] Example 3 Extraction and purification of EGFP-CTA2-TAT fusion protein
[0053] (1) Suspend the wet bacteria obtained in Example 2 in lysis buffer (PBS buffer) (wet bacteria: lysis buffer = 1 g: 10 mL); add lysozyme (final concentration 80 μg / mL) and use magnetic Stir evenly with a stirrer; put the above mixture in the refrigerator for repeated freezing and thawing, if the bacterial solution is still viscous after repeated freezing and thawing, add DNase for further cracking;
[0054] (2) When the bacterium in step (1) is fully lysed to ensure that it is no longer viscous, use a refrigerated centrifuge to centrifuge at 4°C and 10,000r / min for 10min, discard the precipitate and collect the supernatant to obtain a supernatant protein solution;
[0055] (3) Chromatographic column wet packing (Ni-Sepharose 6FF (His tag purification resin)), connect the chromatographic instruments (nucleic acid protein detector, peristaltic pump, chromatographic column) to take over each tube...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com